News & Updates

[PD Test]IN CONVERSATION: Prof Nelson Abelardo talks about the benefits of nebivolol beyond BP lowering

IN CONVERSATION: Prof Nelson Abelardo talks about the benefits of nebivolol beyond BP lowering

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

New drug applications approved by US FDA as of 16-31 May 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Breastfeeding delivers long-term cardiometabolic benefits in offspring

In a secondary analysis of the HAPO FUS*, breastfeeding was found to be associated with lower rate of glucose metabolism disorders in the offspring; however, this association was not seen among the mothers.

Nintendo Wii Sports may help rehabilitate patients

Playing Nintendo Wii^TM may help rehabilitate stroke patients as an adjunct to conventional therapy, a recent study revealed. The investigators conducted a randomized controlled trial on the effectiveness of virtual reality using Nintendo Wii^TM Sports (Tennis) as an adjunct to the conventional therapy in upper limb stroke rehabilitation in a tertiary hospital. They determined and compared the upper limb gross motor responses among patients with upper limb weakness post-stroke treated with Nintendo Wii^TM tennis as an adjunct to physical and occupational therapy versus conventional therapy alone.

Robot-assisted rehab may be superior to usual therapy

ITSH article 2.2

Extended clopidogrel monotherapy after a 9- to 12-month course of dual antiplatelet therapy (DAPT) reduces bleeding and ischaemic events in patients with acute coronary syndrome (ACS) who are at high risk for both events, according to the OPT-BIRISK* trial presented at ESC 2023.

Is a low-GI Mediterranean diet better for people with high cardiometabolic risk?

A low-glycaemic index (GI) diet, based on a Mediterranean dietary (MedDiet) pattern, provides no substantial impact on major cardiometabolic risk factors at fasting in individuals at high cardiometabolic risk when compared with a high-GI MedDiet, a study has shown.

BP-lowering meds spell small increase in eczematous dermatitis rates for older adults

The use of blood pressure (BP)-lowering medications may slightly raise the incidence of eczematous dermatitis among older adults, with the magnitude of effect being largest for calcium channel blockers and diuretic drugs and smallest for angiotensin-converting enzyme (ACE) inhibitors and β-blockers, according to a study.